Osteopontin promotes inflammation in patients with acute coronary syndrome through its activity on IL-17 producing cells

European Journal of Immunology

Volumn 42, Issue 10, 2012, Pages 2803-2814

  Zheng, Yingxia ^a   Wang, Zhihao ^a   Deng, Lin ^a   Yuan, Xiangliang ^a   Ma, Yanhui ^a   Zhang, Guanghui ^a   Gantier, Michael P ^b   Liu, Jun Ping ^c   Shen, Lisong ^a   Xu, Dakang ^b,c  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MONASH UNIVERSITY   (Australia)

^c HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; CD29; IL 17; Osteopontin; Th17; Treg cells

Indexed keywords

BETA1 INTEGRIN; CD44V ANTIGEN; CD45RA ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 6; OSTEOPONTIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; SERUM; T LYMPHOCYTE;

ACUTE CORONARY SYNDROME; AGED; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; INTERLEUKIN-17; MALE; MIDDLE AGED; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; OSTEOPONTIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; UP-REGULATION;

EID: 84867211431     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242475     Document Type: Article

References (36)

1. Libby, P., Inflammation in atherosclerosis. Nature 2002. 420: 868-874.
2. Frostegard, J., Ulfgren, A. K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U. and Hansson, G. K., Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999. 145: 33-43.
3. Laurat, E., Poirier, B., Tupin, E., Caligiuri, G., Hansson, G. K., Bariety, J. and Nicoletti, A., In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 2001. 104: 197-202.
4. Ouyang, W., Kolls, J. K. and Zheng, Y., The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008. 28: 454-467.
5. Dong, C., Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 2006. 6: 329-333.
6. Eid, R. E., Rao, D. A., Zhou, J., Lo, S. F., Ranjbaran, H., Gallo, A., Sokol, S. I. et al., Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009. 119: 1424-1432.
7. Cheng, X., Yu, X., Ding, Y. J., Fu, Q. Q., Xie, J. J., Tang, T. T., Yao, R. et al., The Th17/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 2008. 127: 89-97.
8. Veldhoen, M., Hocking, R. J., Flavell, R. A. and Stockinger, B., Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 2006. 7: 1151-1156.
9. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
10. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231-234.
11. Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P. et al., IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2008. 105: 18460-18465.
12. Xu, L., Kitani, A., Fuss, I. and Strober, W., Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 2007. 178: 6725-6729.
13. Koenen, H. J., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. and Joosten, I., Human CD25 high Foxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008. 112: 2340-2352.
14. Valmori, D., Raffin, C., Raimbaud, I. and Ayyoub, M., Human RORgammat+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors. Proc. Natl. Acad. Sci. USA 2010. 107: 19402-19407.
15. Wang, K. X. and Denhardt, D. T., Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 2008. 19: 333-345.
16. Giachelli, C. M., Bae, N., Almeida, M., Denhardt, D. T., Alpers, C. E. and Schwartz, S. M., Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 1993. 92: 1686-1696.
17. Fitzpatrick, L. A., Severson, A., Edwards, W. D. and Ingram, R. T., Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J. Clin. Invest. 1994. 94: 1597-1604.
18. Isoda, K., Kamezawa, Y., Ayaori, M., Kusuhara, M., Tada, N. and Ohsuzu, F., Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 2003. 107: 679-681.
19. Matsui, Y., Rittling, S. R., Okamoto, H., Inobe, M., Jia, N., Shimizu, T., Akino, M. et al., Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2003. 23: 1029-1034.
20. Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J. et al., Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 2006. 7: 929-936.
21. Shinohara, M. L., Kim, J. H., Garcia, V. A. and Cantor, H., Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 2008. 29: 68-78.
22. Chen, G., Zhang, X., Li, R., Fang, L., Niu, X., Zheng, Y., He, D. et al., Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheum. 2010. 62: 2900-2908.
23. Minoretti, P., Falcone, C., Calcagnino, M., Emanuele, E., Buzzi, M. P., Coen, E. and Geroldi, D., Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur. Heart J. 2006. 27: 802-807.
24. Shen, L. S., Wang, J., Shen, D. F., Yuan, X. L., Dong, P., Li, M. X., Xue, J. et al., CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T-cell proliferation and contribute to gastric cancers progression. Clin. Immunol. 2009. 131: 109-118.
25. Yuan, X. L., Chen, L., Li, M. X., Dong, P., Xue, J., Wang, J., Zhang, T. T. et al., Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin. Immunol. 2010. 134: 277-288.
26. Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C. et al., Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009. 30: 899-911.
27. Butcher, M. and Galkina, E., Current views on the functions of interleukin-17A-producing cells in atherosclerosis. Thromb. Haemost. 2011. 106: 787-795.
28. Coskun, S., Atalar, E., Ozturk, E., Yavuz, B., Ozer, N., Goker, H., Ovunc, K. et al., Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes. J. Natl. Med. Assoc. 2006. 98: 1746-1750.
29. Zahradka, P., Novel role for osteopontin in cardiac fibrosis. Circ. Res. 2008. 102: 270-272.
30. Szalay, G., Sauter, M., Haberland, M., Zuegel, U., Steinmeyer, A., Kandolf, R. and Klingel, K., Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ. Res. 2009. 104: 851-859.
31. Mor, A., Luboshits, G., Planer, D., Keren, G. and George, J., Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur. Heart. J. 2006. 27: 2530-2537.
32. Voo, K. S., Wang, Y. H., Santori, F. R., Boggiano, C., Arima, K., Bover, L., Hanabuchi, S. et al., Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. USA 2009. 106: 4793-4798.
33. Ayyoub, M., Deknuydt, F., Raimbaud, I., Dousset, C., Leveque, L., Bioley, G. and Valmori, D., Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc. Natl. Acad. Sci. USA 2009. 106: 8635-8640.
34. Deknuydt, F., Bioley, G., Valmori, D. and Ayyoub, M., IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin. Immunol. 2009. 131: 298-307.
35. Behera, R., Kumar, V., Lohite, K., Karnik, S. and Kundu, G. C., Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 2010. 31: 192-200.
36. Fan, K., Dai, J., Wang, H., Wei, H., Cao, Z., Hou, S., Qian, W. et al., Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells. Arthritis Rheum. 2008. 58: 2041-2052.